Lippincott Williams & Wilkins

SHERPA: Unknown

People

  1. Reidy
    Reidy
  2. Raj
    Raj
  3. Bodei
    Bodei
  4. O'Reilly
    O'Reilly
  5. Tang
    Tang
  6. Capanu
    Capanu
  7. Chou
    Chou
  8. Saltz
    Saltz
  9. Untch
    Untch
  10. Basturk
    Basturk

Groups

  1. Center for Pancreatic Cancer Research (68)
  2. Department of Medicine (64)
  3. Solid Tumor Oncology Division (59)
  4. Gastrointestinal Oncology Service (58)
  5. Sloan Kettering Institute Postdocs (24)
  6. Radiology, Department of (23)
  7. Epidemiology and Biostatistics (19)
  8. Molecular Imaging and Therapy Service (17)
  9. Surgery (17)
  10. Biostatistics Service (14)
Search Within
  1. "Pancreas"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (40)
  3. Review (3)
  4. Guidelines (2)
  5. Correspondence (1)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (68)
  2. Department of Medicine (64)
  3. Solid Tumor Oncology Division (59)
  4. Gastrointestinal Oncology Service (58)
  5. Sloan Kettering Institute Postdocs (24)
  6. Radiology, Department of (23)

More Groups

People
  1. Diane Reidy (43)
  2. Nitya Raj (27)
  3. David Klimstra (21)
  4. Lisa Bodei (16)
  5. Eileen O'Reilly (12)
  6. Laura Tang (12)

More People

Years
  1. 2022 (11)
  2. 2021 (10)
  3. 2020 (9)
  4. 2019 (10)
  5. 2018 (15)
  6. 2017 (15)

More Years

Publications
  1. Pancreas (116)

Results (116)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Helping patients understand pancreatic cancer using animated pancreas patient education with visual formats of learning
    Journal Article

    Munigala, S.; Gardner, T. B.; O'Reilly, E. M.; Fernández-Del Castillo, C.; Ko, A. H.; Pleskow, D.; Vollmer, C. M. Jr; Searle, N. A.; Bakelman, D.; Holt, J. M.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Early onset well-differentiated pancreatic neuroendocrine tumors: clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C.; Reidy-Lagunes, D.; Wei, A.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Safety, pharmacodynamic, and antitumor activity of tidutamab, an SSTR2 x CD3 bispecific antibody, in subjects with advanced neuroendocrine tumors
    Meeting Abstract

    El-Rayes, B. F.; Hendifar, A. E.; Pant, S.; Wilky, B. A.; Reilley, M. J.; Benson, A. B.; Chow, W. A.; Konda, B.; Starr, J.; Ahn, D. H.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab-based therapy in previously treated extrapulmonary poorly-differentiated neuroendocrine carcinomas: Results of part B (pembrolizumab plus chemotherapy)
    Meeting Abstract

    Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Hope, T. A.; Kolli, K. P.; Zhang, L.; Fattah, D.; Calabrese, S.; Grabowsky, J. A.; Perez, K.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • The phase 3 NETTER-1 study of (177)Lu-DOTATATE in patients with midgut neuroendocrine tumors: Updated progression-free survival analyses
    Meeting Abstract

    Kunz, P. L.; Benson, A.; Bodei, L.; Grande, E.; Mittra, E.; Kulke, M. H.; Yao, J. C.; Wolin, E. M.; Niepel, D.; Demange, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schöder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of neuroendocrine neoplasms (NENs) treated with immune checkpoint inhibitors (ICIs): A single institution experience
    Meeting Abstract

    Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy-Lagunes, D.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Lanreotide autogel/depot (LAN) in patients with advanced bronchopulmonary (BP) neuroendocrine tumors (NETs): Results From the phase 3 SPINET study
    Meeting Abstract

    Reidy-Lagunes, D.; Hörsch, D.; Singh, S.; Caplin, M. E.; Ferone, D.; Wolin, E. M.; Capdevila, J.; Buikhuisen, W.; Raderer, M.; Dansin, E.; more...
    Pancreas (2022)

    Fulltext@MSK | Save